You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
振德醫療(603301.SH):許昌振德擬收購上海亞澳及三特瑞100%股權
格隆匯 08-31 19:02

格隆匯8月31日丨振德醫療(603301.SH)公佈,公司全資子公司許昌振德醫用敷料有限公司(“許昌振德”)擬以現金方式收購上海亞澳醫用保健品有限公司(“上海亞澳”)100%股權和三特瑞(南通)醫用材料有限公司(“三特瑞”)100%股權,轉讓價款分別為人民幣4億元和1.12億元。

此次交易完成後,上海亞澳和三特瑞將成為公司的全資孫公司,納入公司合併財務報表範圍。

次交易標的上海亞澳主要從事以中心靜脈留置感控防護以及傷口護理解決方案(現代傷口護理產品)為核心產品生產、研發和銷售,三特瑞主要為上海亞澳提供部分產品生產配套和滅菌服務,上海亞澳和三特瑞的業務與公司業務高度協同。交易標的產品主要銷往境外,其中上海亞澳2020年度境外銷售佔銷售額的85%。上海亞澳和三特瑞實際控制人同為HongLeungFredrikWAI(澳大利亞國籍)。

次收購與公司打造以傷口造口護理產品和感控產品為核心的產品和市場戰略高度契合,藉助公司在內外銷渠道特別是內銷渠道優勢、客户的優勢和本次交易標的在現代傷口護理產品、感控產品等方面的產品力優勢,形成協同效應,搶抓現代傷口護理領域國產替代的機遇,快速擴大公司在現代傷口和感控產品的業務規模,進一步優化公司產品結構,提升整體產品競爭力和市場佔有率,符合公司戰略發展規劃。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account